Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Proactively manage your pharmacy inventory
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods and devices for providing prolonged drug therapy|
|Abstract:||Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal tract at an ascending release rate over an extended time period are provided. The dosage forms may additionally comprise an immediate-release dose of drug.|
|Inventor(s):||Lam; Andrew C. (Palo Alto, CA), Shivanand; Padmaja (Palo Alto, CA), Ayer; Atul D (Palo Alto, CA), Hatamkhany; Zahedeh (Palo Alto, CA), Weyers; Richard G (Palo Alto, CA), Gupta; Suneel K. (Palo Alto, CA), Guinta; Diane R (Palo Alto, CA), Christopher; Carol A. (Palo Alto, CA), Saks; Samuel R. (Palo Alto, CA), Hamel; Lawrence G. (Palo Alto, CA), Wright; Jeri D. (Palo Alto, CA)|
|Assignee:||ALZA Corporation (Palo Alto, CA)|
1. A method for treating Attention-Deficit Hyperactivity Disorder in a subject comprising: administering to said subject an osmotic dosage form comprising a capsule-shaped
longitudinally compressed tablet core containing a plurality of layers wherein drug is contained in at least one layer and at least one other layer comprises a suitable fluid-expandable polymer, wherein said drug comprises methylphenidate hydrochloride;
a semipermeable wall that surrounds said longitudinally compressed tablet core to form a compartment that has an osmotic gradient that drives fluid from an external fluid environment contacting said semipermeable wall into said compartment; and an
orifice that is formed through said semipermeable wall at a location adjacent to the first layer that permits drug to be released from the compartment into said external fluid environment, wherein the dosage form releases the drug over a period
comprising a first, second, and third sequential time intervals of equal duration, and wherein the dosage form releases more of said drug during said second interval than during said first interval and more of said drug during said third interval than
during said second interval.
2. The method according to claim 1 wherein said period of release comprises a fourth sequential time interval, and wherein the dosage form releases more of said drug during said fourth interval than during said third interval.
3. The method according to claim 1 further comprising an outer surface and an immediate-release dosage of the drug applied as a coating onto the outer surface.
4. The method according to claim 3 wherein the dosage form releases more of said drug during said second interval than during said first interval, not including drug released from said coating during said first interval.
5. The method according to claim 4 wherein each of said time intervals is 30 minutes.
6. The method according to claim 4 wherein each of said time intervals is 1 hour.
7. The method according to claim 5 wherein the drug released during said first interval does not include any drug released from said first layer of said dosage form.
8. The method according to claim 6 wherein the drug released during said first interval does not include any drug released from said first layer of said dosage form.
9. The method according to claim 1 wherein said dosage form is administered orally.
10. The method according to claim 1 wherein said dosage form is administered one time per day for multiple days.
11. The method according to claim 1 wherein said dosage form is administered to a non-adult subject.
12. The method according to claim 1 wherein said dosage form further comprises a third layer comprising an additional portion of said drug, wherein said third layer is disposed between said other drug containing layer and said fluid-expandable polymer layer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.